Clinical trials, pharmaceutical companies and clinical practice;Ensayos clínicos, industria farmacéutica y práctica clínica

Anales del Sistema Sanitario de Navarra

Volumn 28, Issue 1, 2005, Pages 7-16

  Peralta, V ^a  

^a Universidad Pública de Navarra   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; DECISION MAKING; DRUG INDUSTRY; DRUG INFORMATION; DRUG QUALITY; DRUG USE; EDITORIAL; HUMAN; MEDICAL ETHICS; MEDICAL LITERATURE; METHODOLOGY; PRESCRIPTION;

CLINICAL TRIALS; CONFLICT OF INTEREST; DRUG INDUSTRY; ETHICS, CLINICAL; ETHICS, RESEARCH; HUMANS; PHYSICIANS; RESEARCH; SCIENTIFIC MISCONDUCT;

EID: 17144397595     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (13)

1. COYLE SL. Physician-Industry relations. Part 1: Individual physicians. Ann Intern Med 2002; 136: 396-402.
2. TONELLI MR. The philosophical limits of evidence-based medicine. Acad Med 1998; 73: 1234-1240.3.
3. ZARIN DA, YOUNG JL, WEST JC. Challenges to evidence-based medicine: A comparison of patients and treatments in randomized controlled trials with patients and treatments in a practice research network. Soc Psychiatry Psychiatr Epidemiol 2005; 40: 27-35.
4. CHO MK, BERO LA. The quality of drug studies in symposium proceedings. Ann Intern Med 1996; 124: 485-489.
5. LEXCHIN J, BERO LA, DJULBEGOVIC B, CLARK O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. Brit Med J 2003; 326: 1-10.
6. FRISS S. To what extent should papers submitted from drug companies be published in medical journals? Acta Psychiatr Scand 1999; 99: 157-159.
7. SAFER DJ. Design and reporting modifications in industry-sponsored comparative psychopharmachology trials. J Nerv Mental Dis 2002; 190: 583-592.
8. MELANDER H, AHLQVIST-RASTAD J, MEIJER G, BEERMANN B. Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. Brit Med J 2003; 326: 1171-1173.
9. CARPENTER WT. How the doctor can counter commercial bias in the dissemination of pharmacotherapeutic knowledge. J Nerv Mental Dis 2002; 190: 593-596.
10. DANA J, LOEWENSTEIN G. A social science perspective on gifts to physicians from industry. JAMA 2003; 290: 252-255.
11. PERALTA V, CUESTA MJ. Factores predictores de la respuesta al tratamiento antipsicótico: problemas metodológicos. Aula Médica Psiquiatría 1999; 1: 98-106.
12. COYLE SL. Physician-Industry relations. Part 2: Organizational issues. Ann Intern Med 2002; 136: 403-406.
13. GÓMEZ DE LA CÁMARA A. La medicina basada en la evidencia científica: mito o realidad de la variabilidad de la práctica clínica y su repercusión en los estados de salud. An Sist Sanit Navar 2002; 25: 11-26.